Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 848 participants.
Also called NCT06530537
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 848 participants
- Registry
-
NCT06530537
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06530537. Randomized; no masking; primary purpose treatment. Start 2024-07-18 (actual); primary completion 2031-08-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds
- Condition
- Cerebral Microbleeds
- Condition
- Stroke
- Intervention (Drug)
- Cilostazol
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Zhejiang Provincial People's Hospital
Record details
- Record id
cardio:ct-nct06530537- Content hash
24264dd42a9f27b86a790e4fb709d3fed22a3f7cb25dc38c91d45976716cef54